4//SEC Filing
ALBANY MOLECULAR RESEARCH INC 4
Accession 0001638599-17-000176
CIK 0001065087operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:05 PM ET
Size
8.3 KB
Accession
0001638599-17-000176
Insider Transaction Report
Form 4
Hagen Steven R
VP Pharmaceutical Dev & Mfg
Transactions
- Award
Common Stock
2017-02-08+4,484→ 40,867 total - Award
Common Stock
2017-02-08+5,975→ 36,383 total - Award
Option to Purchase Common Stock
2017-02-08+29,412→ 29,412 totalExercise: $18.41Exp: 2027-02-08→ Common Stock (29,412 underlying)
Footnotes (1)
- [F1]Option is exercisable as to 1/4th of the shares annually on the anniversary date of the grant for each of the next four years.
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001065087
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:05 PM ET
- Size
- 8.3 KB